Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT

NCT06348602 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Ocular Graft-versus-host Disease

Interventions

DRUG: Cyclosporine ophthalmic solution 0.1%
DRUG: Tacrolimus ophthalmic ointment 0.03%

Sponsor

Hospital Universitario Dr. Jose E. Gonzalez